SEC Filings &Disclosures
Explore BioAdaptives' official SEC filings, financial reports, and corporate disclosures, synchronized directly from SEC EDGAR.
Every entry below is the official SEC record, linked directly to EDGAR — the primary document and the complete filing index with exhibits.
- Total filings
- 175
- Historical coverage
- May 3, 2013 — November 4, 2026
Automatically synchronized with SEC EDGAR.
Filing archive
- 8-K
Definitive Agreement to Acquire Xycota Biosciences LLC.
Item 1.01 · Entry into a Material Definitive Agreement · Item 3.02 · Unregistered Sales of Equity Securities · Item 7.01 · Regulation FD Disclosure · Item 9.01 · Financial Statements and Exhibits
- 4
- 4
- 10-Q
FORM 10-Q
- NT 10-Q
FORM NT 10-Q
- 4
- 4
- 4
- 10-Q
FORM 10-Q
- 4
- 10-K
FORM 10-K
- 4
- NT 10-K
FORM NT 10-K
- 4
- 4
- 4
- 4
- 10-Q
FORM 10-Q
- 4
- 4
- 4
- 10-Q
FORM 10-Q
- 4
- 4
- 4
Source: U.S. Securities and Exchange Commission, EDGAR (CIK 0001575142). Descriptions are taken from SEC filing metadata. The official SEC record governs.